2 months ago
VKTX
AnalystsJay OlsonJay Olson's Stock Forecasts
AnalystsJay Olson
Analyst Ranking
Top 2%
#90 out of 4587 analysts
Average Return
+20.21%
Win Rate
50%87 out of 175
Risk vs Reward
Poor
Good
Jay Olson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +578.03% | $2.64 | $17.90 | 2022-05-13 - 2023-05-12 | Buy |
89bio IncETNB | +450.31% | $3.22 | $17.72 | 2022-06-30 - 2023-06-29 | Buy |
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-28 - 2024-03-27 | Buy |
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-10 - 2023-05-09 | Buy |
Prothena Corp Public Ltd CoPRTA | +357.12% | $12.08 | $55.22 | 2020-07-09 - 2021-07-08 | Buy |
Jay Olson Analyst Color
Get additional color on Jay Olson's coverage of popular stocks
2 months ago
VKTX
3 months ago
VKTX
a year ago
VKTX
Jay Olson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Voyager Therapeutics IncVYGR | 5 | Buy | $18.00 | +113.52% | Maintains | 4 days ago |
Sutro Biopharma IncSTRO | 5 | Buy | $10.00 | +149.38% | Maintains | 4 days ago |
Crispr Therapeutics AgCRSP | 6 | Buy | $95.00 | +68.98% | Maintains | 9 days ago |
Acadia Pharmaceuticals IncACAD | 11 | Hold | $19.00 | +28.47% | Maintains | 14 days ago |
Neurocrine Biosciences IncNBIX | 11 | Buy | $216.00 | +51.80% | Maintains | 18 days ago |
Biogen IncBIIB | 19 | Buy | $270.00 | +17.10% | Maintains | 20 days ago |
Incyte CorpINCY | 8 | Buy | $84.00 | +47.11% | Maintains | a month ago |
Sage Therapeutics IncSAGE | 6 | Hold | $17.00 | +45.30% | Maintains | a month ago |
Revolution Medicines IncRVMD | 6 | Buy | $45.00 | +14.18% | Maintains | a month ago |
Skye Bioscience IncSKYE | 1 | Buy | $25.00 | +107.47% | Initiates Coverage On | a month ago |
Q32 Bio IncQTTB | 1 | Buy | $50.00 | +64.69% | Initiates Coverage On | a month ago |
Ionis Pharmaceuticals IncIONS | 3 | Buy | $75.00 | +101.02% | Maintains | a month ago |
Viking Therapeutics IncVKTX | 7 | Buy | $138.00 | +105.97% | Maintains | 2 months ago |
Cognition Therapeutics IncCGTX | 4 | Buy | $9.00 | +359.18% | Maintains | 2 months ago |
Madrigal Pharmaceuticals IncMDGL | 7 | Buy | $375.00 | +70.41% | Maintains | 2 months ago |
Marinus Pharmaceuticals IncMRNS | 5 | Hold | $9.00 | +576.69% | Maintains | 2 months ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $80.00 | +247.52% | Maintains | 2 months ago |
Immuneering CorpIMRX | 1 | Buy | $25.00 | +1,600.68% | Reiterates | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 8 | Buy | $80.00 | +255.24% | Maintains | 3 months ago |
Amgen IncAMGN | 16 | Buy | $350.00 | +12.01% | Reiterates | 4 months ago |
Biovie IncBIVI | 4 | Buy | $5.00 | +916.26% | Maintains | 6 months ago |
Enanta Pharmaceuticals IncENTA | 7 | Hold | $21.00 | +73.12% | Maintains | 6 months ago |
Intellia Therapeutics IncNTLA | 7 | Buy | $70.00 | +166.97% | Maintains | 6 months ago |
Immunogen IncIMGN | 1 | Hold | $16.00 | -48.77% | Initiates Coverage On | 7 months ago |
Exelixis IncEXEL | 3 | Buy | $29.00 | +38.69% | Maintains | 9 months ago |
Mirati Therapeutics IncMRTX | 7 | Buy | $62.00 | +5.62% | Maintains | 9 months ago |
Editas Medicine IncEDIT | 5 | Hold | $12.00 | +113.52% | Reiterates | 10 months ago |
Galecto IncGLTO | 2 | Buy | $12.00 | +1,832.37% | Reiterates | 10 months ago |
Denali Therapeutics IncDNLI | 3 | Buy | $68.00 | +231.55% | Maintains | a year ago |
Cymabay Therapeutics IncCBAY | 3 | Buy | $16.00 | N/A | Maintains | a year ago |
89bio IncETNB | 4 | Buy | $30.00 | N/A | Reiterates | a year ago |
Karuna Therapeutics IncKRTX | 4 | Buy | $280.00 | N/A | Reiterates | a year ago |
Bicycle Therapeutics PLCBCYC | 2 | Buy | $55.00 | N/A | Reiterates | a year ago |
Seagen IncSGEN | 8 | Buy | $229.00 | N/A | Maintains | a year ago |
Nektar TherapeuticsNKTR | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Cincor Pharma IncCINC | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Ayala Pharmaceuticals IncAYLA | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Relmada Therapeutics IncRLMD | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Sierra Oncology IncSRRA | 2 | Hold | $55.00 | N/A | Downgrades | 2 years ago |
Focus Financial Partners IncFOCS | 1 | Buy | $71.00 | N/A | Maintains | 3 years ago |
Korro Bio IncKRRO | 2 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $46.00 | N/A | Downgrades | 4 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | $2.00 | N/A | Downgrades | 4 years ago |
Mediwound LtdMDWD | 1 | Buy | $84.00 | N/A | Maintains | 6 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $2,520.00 | N/A | Maintains | 6 years ago |
Medicines CoMDCO | 2 | Buy | N/A | N/A | Upgrades | 6 years ago |
Neuroderm LtdNDRM | 2 | Buy | $42.00 | N/A | Upgrades | 7 years ago |
Therapeuticsmd IncTXMD | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.